RT Journal Article
SR Electronic
T1 Naproxen Parenteral Formulation Studies
JF PDA Journal of Pharmaceutical Science and Technology
JO PDA J Pharm Sci Technol
FD Parenteral Drug Association (PDA)
SP 336
OP 342
VO 44
IS 6
A1 Peswani, K. S.
A1 Lalla, J. K.
YR 1990
UL http://journal.pda.org/content/44/6/336.abstract
AB Naproxen sodium has been formulated in a parenteral dosage form. After a series of experiments involving solubility, pH, and excipient compatibility using Placket Burman experimental design, the formulation has been finalized. The accelerated stability studies on samples stored at high temperatures projected the shelf life to be 4.2 years. Toxicological, therapeutic efficacy, and other aspects of this formulation are being reported separately